Latest Headlines

Latest Headlines

Illumina finds match in Australian genomics company for transplant sequencing work

Illumina is off to a racing start in 2016, and the pace isn't showing any signs of slowing. The company is snatching up Conexio Genomics to get its hands on Conexio's transplant genotyping products, a couple of weeks after it unveiled its liquid biopsy spinoff and expanded genomics offerings.

Industry Voices: Inside Genomics--Q&A with Bina CEO Narges Bani Asadi and Dr. Ralph Snyderman

One of the elements lacking in the personalized medicine discussion today is the perspective of leading clinicians, informaticists and academics working in the field. To remedy the gap, I've asked a series of leaders in the industry to offer up their views.

Next-gen sequencing tech from GenapSys nets $37M round

Genomic sequencing specialist GenapSys picked up $37 million in Series B financing to help develop and commercialize its diagnostic system for genetic diseases, cancer and microbes.

Illumina taps Hamilton Robotics for sequencing automation

Illumina has partnered with Hamilton Robotics to develop automated sample preparation for the company's next-generation sequencing platforms.

Life Tech accepts Thermo's $13.6B bid

After months of hints and allegations, Thermo Fisher has come out on top in the scrum to acquire Life Technologies, signing a deal to buy the sequencing giant for $13.6 billion.

GE launches cancer assay with eye on companion Dx

GE Healthcare has been steadily building up its diagnostics offerings over the past three years, and now the company is launching a sequencing assay targeting solid tumors in clinical trials.

Report: Life Tech may have found a buyer after all

The hot and cold rumors over a potential Life Technologies sale have swung back toward the former, as  Bloomberg 's sources say a team of private equity outfits are exploring an offer for the sequencing giant.

Troubled sequencing pioneer Helicos shelters in bankruptcy court

Delisted and largely dumped by investors after a pair of restructurings failed to cure what ailed it, Cambridge, MA-based Helicos BioSciences ($HLCS) has stepped into bankruptcy court seeking Chapter 11 protection for the genomic sequencing company.

Third Rock's Levin calls for teamwork in personalized medicine

Personalized medicine has the potential to revolutionize biotech and pharma, but only if stakeholders work together, Levin said.

Life Technologies expands manufacturing in Scotland

Life Technologies is lining up its pieces to get more of the genetic sequencing market with a manufacturing plant expansion in Scotland.